Marker Therapeutics MRKR
NASDAQ MRKR
$1.41 +0.19 (+15.98%)
As of: Aug 21, 2026 · 11:47 AM EDT

Marker Therapeutics (MRKR) Net Margin (QoQ) (2022 - 2025)

Marker Therapeutics (MRKR) Net Margin (QoQ) (2022 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.94 Bn 132.09 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.59 Bn 78.60 Bn 3.93 Bn
3 Argenx Se 65.67 Bn 60.49 Bn 1.37 Bn
4 Moderna 57.81 Bn 52.67 Bn 52.00 Mn
5 BeOne Medicines 42.25 Bn 37.15 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.76 Bn 28.45 Bn 992.69 Mn
7 BioNTech SE 28.41 Bn 10.02 Bn 668.28 Mn
8 Insmed 27.58 Bn 26.42 Bn 358.27 Mn
9 Royalty Pharma 27.24 Bn 26.41 Bn -
10 Marker Therapeutics 27.33 Mn 15.40 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -4,468.00
Sep 30, 2025 31,909.00
Jun 30, 2025 89,240.00
Mar 31, 2025 -118,861.00
Dec 31, 2024 -5,003.00
Sep 30, 2024 3,438.00
Jun 30, 2024 8,088.00
Sep 30, 2023 18,060.00
Jun 30, 2023 -128,534.00
Mar 31, 2023 7,739.00
Dec 31, 2022 1,224.00
Sep 30, 2022 38,811.00
Jun 30, 2022 54,071.00